Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis

Author： Podesta M.   Piaggio G.   Sessarego M.   Pitto A.   Figari O.   Soracco M.   Carella A.M.   Dejana A.   Rosti V.   Fugazza G.   Ravera G.   Lerma E.   Cazzola M.   Bacigalupo A.   Frassoni F.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.28, Iss.2, 2000-02, pp. : 210-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hemopoiesis in Ph-Negative Chronic Myeloproliferative Disorders

By  

Current Stem Cell Research & Therapy, Vol. 4, Iss. 2, 2009-05 ,pp. : 154-160

Bentham Science Publishers

Access to resources Recommend Favorite

Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia

By Michiels Jan   Berneman Zwi   Schroyens Wilfried   Kutti Jack   Swolin Birgitta   Ridell Börje   Fernando Pagani   Zanetto Ulises  

Annals of Hematology, Vol. 83, Iss. 8, 2004-08 ,pp. : 504-512

Springer Publishing Company

Access to resources Recommend Favorite

Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: A metabolic adaptation?

By Mazzotta Serena   Guerranti Roberto   Gozzetti Alessandro   Bucalossi Alessandro   Bocchia Monica   Sammassimo Simona   Petralia Salvatore   Ogueli Godwin Ifeanyi   Lauria Francesco  

Hematology, Vol. 11, Iss. 4, 2006-08 ,pp. : 239-244

Maney Publishing

Access to resources Recommend Favorite

Determination of α-1 Acid Glycoprotein in Patients with Ph+ Chronic Myeloid Leukemia during the First 13 Weeks of Therapy with STI571

By le Coutre P.   Kreuzer K-A.   Na I-K.   Lupberger J.   Holdhoff M.   Appelt C.   Schwarz M.   Müller C.   Gambacorti-Passerini C.   Platzbecker U.   Bonnet R.   Ehninger G.   Schmidt C.A.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 1, 2002-01 ,pp. : 75-85

Academic Press

Access to resources Recommend Favorite

The tyrosine kinase inhibitor STI571, like interferon- , preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia

By Marley S.B.   Deininger M.W.N.   Davidson R.J.   Goldman J.M.   Gordon M.Y.  

Experimental Hematology, Vol. 28, Iss. 5, 2000-05 ,pp. : 551-557

Elsevier

Access to resources Recommend Favorite